Skip to main content
Erschienen in: Lung 4/2013

01.08.2013

Recruitment and Phenotypic Characteristics of Interleukin 9-Producing CD4+ T Cells in Malignant Pleural Effusion

verfasst von: Xiao-Ning Bu, Qiong Zhou, Jian-Chu Zhang, Zhi-Jian Ye, Zhao-Hui Tong, Huan-Zhong Shi

Erschienen in: Lung | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Our previous data have demonstrated that the number of IL-9-producing CD4+ T cells (Th9 cells) in malignant pleural effusion (MPE) was significantly increased when compared with that in blood. The aim of the present study was to investigate the mechanism by which Th9 cells were recruited into MPE and the phenotypic characteristics of pleural Th9 cells.

Methods

The expression patterns of chemokine receptors (CCRs) on Th9 cells and the chemoattractant activity of chemokine CCL20 for Th9 cells in vitro were observed. The phenotypic features of Th9 cells in MPE were determined by flow cytometry.

Results

We found that Th9 cells in both MPE and blood expressed a high level of CCR6 on their surface. An in vitro migration assay confirmed that both MPE and supernatants of cultured pleural mesothelial cells could induce the migration of Th9 cells, and anti-CCL20 mAb significantly inhibited the ability of MPE or supernatants to stimulate Th9 cell chemotaxis. We also noted that pleural Th9 cells expressed high levels of CD45RO and very low levels of CD45RA and CD62L, displaying the phenotype of effector memory cells.

Conclusions

Our data revealed that recruitment of Th9 cells into MPE could be induced by pleural CCL20 and that the majority of Th9 cells in MPE displayed the phenotype of effector memory cells.
Literatur
1.
Zurück zum Zitat Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ, BTS Pleural Diseases Guideline Group (2010) Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl 2):ii32–ii40PubMedCrossRef Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ, BTS Pleural Diseases Guideline Group (2010) Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl 2):ii32–ii40PubMedCrossRef
2.
Zurück zum Zitat Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJ (2004) Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 170:377–382PubMedCrossRef Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJ (2004) Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 170:377–382PubMedCrossRef
3.
Zurück zum Zitat Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, Martin B, Wilhelm C, Stockinger B (2008) Transforming growth factor-beta ‘reprograms’ the differentiation of T helper two cells and promotes an interleukin 9-producing subset. Nat Immunol 9:1341–1346PubMedCrossRef Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, Martin B, Wilhelm C, Stockinger B (2008) Transforming growth factor-beta ‘reprograms’ the differentiation of T helper two cells and promotes an interleukin 9-producing subset. Nat Immunol 9:1341–1346PubMedCrossRef
4.
Zurück zum Zitat Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, Khoury S, Oukka M, Kuchroo VK (2008) IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9 + IL-10 + Foxp3(−) effector T cells. Nat Immunol 9:1347–1355PubMedCrossRef Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, Khoury S, Oukka M, Kuchroo VK (2008) IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9 + IL-10 + Foxp3(−) effector T cells. Nat Immunol 9:1347–1355PubMedCrossRef
5.
Zurück zum Zitat Stassen M, Schmitt E, Bopp T (2012) From interleukin-9 to T helper 9 cells. Ann NYAcad Sci 1247:56–68PubMedCrossRef Stassen M, Schmitt E, Bopp T (2012) From interleukin-9 to T helper 9 cells. Ann NYAcad Sci 1247:56–68PubMedCrossRef
6.
Zurück zum Zitat Jäger A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK (2009) Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 183:7169–7177PubMedCrossRef Jäger A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK (2009) Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 183:7169–7177PubMedCrossRef
7.
Zurück zum Zitat Chang HC, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL, Jabeen R, McKinley C, Ahyi AN, Han L, Nguyen ET, Robertson MJ, Perumal NB, Tepper RS, Nutt SL, Kaplan MH (2010) The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 11:527–534PubMedCrossRef Chang HC, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL, Jabeen R, McKinley C, Ahyi AN, Han L, Nguyen ET, Robertson MJ, Perumal NB, Tepper RS, Nutt SL, Kaplan MH (2010) The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 11:527–534PubMedCrossRef
8.
Zurück zum Zitat Horka H, Staudt V, Klein M, Taube C, Reuter S, Dehzad N, Andersen JF, Kopecky J, Schild H, Kotsyfakis M, Hoffmann M, Gerlitzki B, Stassen M, Bopp T, Schmitt E (2012) The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma. J Immunol 188:2669–2676PubMedCrossRef Horka H, Staudt V, Klein M, Taube C, Reuter S, Dehzad N, Andersen JF, Kopecky J, Schild H, Kotsyfakis M, Hoffmann M, Gerlitzki B, Stassen M, Bopp T, Schmitt E (2012) The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma. J Immunol 188:2669–2676PubMedCrossRef
9.
Zurück zum Zitat Ye ZJ, Yuan ML, Zhou Q, Du RH, Yang WB, Xiong XZ, Zhang JC, Wu C, Qin SM, Shi HZ (2012) Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection. PLoS One 7:e31710PubMedCrossRef Ye ZJ, Yuan ML, Zhou Q, Du RH, Yang WB, Xiong XZ, Zhang JC, Wu C, Qin SM, Shi HZ (2012) Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection. PLoS One 7:e31710PubMedCrossRef
10.
Zurück zum Zitat Ye ZJ, Zhou Q, Yin W, Yuan ML, Yang WB, Xiong XZ, Zhang JC, Shi HZ (2012) Differentiation and immune regulation of interleukin 9-producing CD4+ T cells in malignant pleural effusion. Am J Respir Crit Care Med 186:1168–1179PubMedCrossRef Ye ZJ, Zhou Q, Yin W, Yuan ML, Yang WB, Xiong XZ, Zhang JC, Shi HZ (2012) Differentiation and immune regulation of interleukin 9-producing CD4+ T cells in malignant pleural effusion. Am J Respir Crit Care Med 186:1168–1179PubMedCrossRef
11.
Zurück zum Zitat Ye ZJ, Zhou Q, Gu YY, Qin SM, Ma WL, Xin JB, Tao XN, Shi HZ (2010) Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion. J Immunol 185:6348–6354PubMedCrossRef Ye ZJ, Zhou Q, Gu YY, Qin SM, Ma WL, Xin JB, Tao XN, Shi HZ (2010) Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion. J Immunol 185:6348–6354PubMedCrossRef
12.
Zurück zum Zitat Ye ZJ, Zhou Q, Yuan ML, Du RH, Yang WB, Xiong XZ, Huang B, Shi HZ (2012) Differentiation and recruitment of IL-22-producing helper T cells stimulated by pleural mesothelial cells in tuberculous pleurisy. Am J Respir Crit Care Med 185:660–669PubMedCrossRef Ye ZJ, Zhou Q, Yuan ML, Du RH, Yang WB, Xiong XZ, Huang B, Shi HZ (2012) Differentiation and recruitment of IL-22-producing helper T cells stimulated by pleural mesothelial cells in tuberculous pleurisy. Am J Respir Crit Care Med 185:660–669PubMedCrossRef
13.
Zurück zum Zitat Qin XJ, Shi HZ, Huang ZX, Kang LF, Mo WN, Wu C (2005) Interleukin-16 in tuberculous and malignant pleural effusions. Eur Respir J 25:605–611PubMedCrossRef Qin XJ, Shi HZ, Huang ZX, Kang LF, Mo WN, Wu C (2005) Interleukin-16 in tuberculous and malignant pleural effusions. Eur Respir J 25:605–611PubMedCrossRef
14.
Zurück zum Zitat Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708–712PubMedCrossRef Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708–712PubMedCrossRef
15.
Zurück zum Zitat Stathopoulos GT, Kalomenidis I (2012) Malignant pleural effusion. Tumor–host interactions unleashed. Am J Respir Crit Care Med 186:487–492PubMedCrossRef Stathopoulos GT, Kalomenidis I (2012) Malignant pleural effusion. Tumor–host interactions unleashed. Am J Respir Crit Care Med 186:487–492PubMedCrossRef
Metadaten
Titel
Recruitment and Phenotypic Characteristics of Interleukin 9-Producing CD4+ T Cells in Malignant Pleural Effusion
verfasst von
Xiao-Ning Bu
Qiong Zhou
Jian-Chu Zhang
Zhi-Jian Ye
Zhao-Hui Tong
Huan-Zhong Shi
Publikationsdatum
01.08.2013
Verlag
Springer US
Erschienen in
Lung / Ausgabe 4/2013
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-013-9474-4

Weitere Artikel der Ausgabe 4/2013

Lung 4/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.